Trend Results : American Cancer Society

Blog Post Results (1-20 of 1116)


Research to uncover factors behind bladder cancer progression receives ACS grant

(Penn State) To find new therapies for aggressive bladder cancer, researchers must first uncover what drives each subtype at the molecular level. That's why the American Cancer Society has awarded a grant to study bladder cancer development...Show More Summary

Leading Cancer Organizations Provide Guidance on Understanding and Managing Immunotherapy Side Effects

New guidelines developed collaboratively by the American Society of Clinical Oncology (ASCO) and the National Comprehensive Cancer Network(r) (NCCN(r)) offer clinicians much needed recommendations for assessment and management of side effects related to immune checkpoint inhibitors.

Phase II trial shows activity of durvalumab in recurrent/metastatic head and neck cancer

(American Society for Radiation Oncology) Analysis of the phase II CONDOR trial indicates that the immune checkpoint inhibitor durvalumab is tolerable among heavily pre-treated patients with recurrent or metastatic head and neck cancer and has the potential to slow growth in tumors with low or negative expression of the PD-L1 protein.

Cabozantinib shows significant first-line activity for differentiated thyroid cancer

(American Society for Radiation Oncology) Results of a new phase II clinical trial indicate that cabozantinib offers an active therapy option for patients with differentiated thyroid cancer (DTC) that has progressed following surgery and treatment with radioactive iodine (RAI). Show More Summary

Nivolumab immunotherapy safe, feasible during chemoradiation for adv. head and neck cancer

(American Society for Radiation Oncology) Analysis of a clinical trial, RTOG Foundation 3504, finds that nivolumab immunotherapy can be administered safely in conjunction with radiation therapy and chemotherapy for patients with newly diagnosed local-regionally advanced head and neck cancers.

Full integration of digital breast tomosynthesis reduces false positive rates, study shows

(American Roentgen Ray Society) Rates of false positive breast cancer screening exams fell significantly after complete integration of diagnostic digital breast tomosynthesis (DBT), potentially leading to higher quality, lower costs, and fewer unnecessary biopsies, according to a study to be presented at the ARRS 2018 Annual Meeting, set for April 22-27 in Washington, DC.

Bacon, coffee, Nutella: These favorite foods have cancer links

last weekNews : USAToday: News

American Cancer Society officials said obesity and a sluggish lifestyle may one day contribute to more cancer deaths than smoking.        

Scientists can now measure activity of key cancer cell-survival protein

(American Society for Biochemistry and Molecular Biology) A recent study from the University of Michigan Life Sciences Institute and the University of California, San Francisco, has opened new options to further develop a potential cancer-fighting therapy, clearing an early hurdle in the lengthy drug-discovery process. Show More Summary

Who's still smoking: Report highlights populations still at risk

(American Cancer Society) Although tobacco control measures have reduced overall smoking rates in the United States, a new report says several vulnerable subpopulations continue to smoke at high rates.

The sugar-attaching enzyme that defines colon cancer

(American Society for Biochemistry and Molecular Biology) Researchers have identified an enzyme that is absent in healthy colon tissue but abundant in colon cancer cells, according to a report in the Jan. 26 issue of the Journal of Biological Chemistry. Show More Summary

Artificial sweetener could someday provide cancer treatments with fewer side effects

(American Chemical Society) Artificial sweeteners are used in diet drinks and foods but also could someday be used as treatments targeting carbonic anhydrase IX (CA IX), a protein associated with aggressive cancers. Although severalShow More Summary

Depressive symptoms linked to shorter survival in patients with head and neck cancer

In a study of patients with head and neck cancer, even mild depressive symptoms were associated with poorer overall survival. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the findings indicate that patients should be screened and treated for depressive symptoms at the time of diagnosis. Show More Summary

Fanconi anemia: Insight from a green plant

(American Society of Plant Biologists) Fanconi anemia is a human genetic disorder with severe effects, including an increased risk of cancer and infertility. Research in plants helps us understand the disease in humans, showing how a key protein functions in the exchange of genetic material.

New registry launched to track, improve the quality of cancer care delivered in the US

(American Society for Radiation Oncology) A registry that tracks the quality of medical care provided to patients receiving cancer treatment launched this month as part of a collaboration between the American Society of Clinical Oncology (ASCO) and the American Society for Radiation Oncology (ASTRO). Show More Summary

New Registry Launched to Track and Improve the Quality of Cancer Care Delivered in the U.S.

A registry that tracks the quality of medical care provided to patients receiving cancer treatment launched this month as part of a collaboration between the American Society of Clinical Oncology (ASCO) and the American Society for Radiation Oncology (ASTRO). Show More Summary

The Future of Cancer Treatment Is Personalized and Collaborative

In an interview at Singularity University’s Exponential Medicine in San Diego, Richard Wender, chief cancer control officer at the American Cancer Society, discussed how technology has changed cancer care and treatment in recent years. Just a few years ago, microscopes were the primary tool used in cancer diagnoses, but we’ve come a long way since. “We […]

The cancer death rate has dropped again. Here's why.

The nation's overall cancer death rate declined 1.7 percent in 2015, the latest indication of steady, long-term progress against the disease, according to a new report by the American Cancer Society. Over nearly a quarter-century, the mortality rate has fallen 26 percent, resulting in almost 2.4...

Cancer mortality in the US continues decades-long drop

(American Cancer Society) The cancer death rate dropped 1.7 percent from 2014 to 2015, continuing a drop that began in 1991 and has reached 26 percent, resulting in nearly 2.4 million fewer cancer deaths during that time.

Cancer Deaths Have Dropped 26% in Recent Years

2 months agoHealth : Time: Healthland

Since 1991, the cancer death rate has dropped by 26%, according to the latest data from the American Cancer Society (ACS). That decline represents nearly 2.4 million lives saved from cancer. The decreasing death rate continues a downward trend in mortality from the disease, which ACS experts say is due to a combination of factors.…

Biomarkers in breast cancer: IQWiG criticizes conclusion on MINDACT data in US guideline

The American Society of Clinical Oncology (ASCO) recently updated its guideline on biomarkers with regard to the MammaPrint test and published this update in the Journal of Clinical Oncology (JCO). On the basis of data from the MINDACT...Show More Summary

Copyright © 2015 Regator, LLC